ICD-9-CM Code | Description |
---|---|
492.8 | Other emphysema |
493.22 | Chronic obstructive asthma with acute exacerbation |
496 | Chronic airway obstruction, not elsewhere classified |
518.81 | Acute respiratory failure |
2012 ICD-9-CM Codes 490-496 : Chronic Obstructive Pulmonary Disease And Allied Conditions. 490 Bronchitis, not specified as acute or chronic. 491 Chronic bronchitis. 492 Emphysema. 493 Asthma. 494 Bronchiectasis. 495 Extrinsic allergic alveolitis. 496 Chronic airway obstruction, not elsewhere classified. 460-519.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALLIED CONDITIONS 490-496 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALLIED CONDITIONS ICD-9 Code range 490-496 The ICD-9 code range CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALLIED CONDITIONS for 490-496 is medical classification list by the World Health Organization (WHO).
ICD-9-CM Diagnosis Codes 496.*. : Chronic airway obstruction, not elsewhere classified. Chronic, irreversible obstruction of air flow from the lungs. 496 Chronic airway obstruction, not elsewhere classified convert 496 to ICD-10-CM.
More recent version (s) of ICD-9-CM 491.20: 2014 2015. 2015/16 ICD-10-CM J44.9 Chronic obstructive pulmonary disease, unspecified. ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 491.20 is one of thousands of ICD-9-CM codes used in healthcare.
A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree.
Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema. A disease of chronic diffuse irreversible airflow obstruction. Subcategories of copd include chronic bronchitis and pulmonary emphysema.
Chronic obstructive pulmonary disease includes chronic bronchitis, in which the bronchi (large air passages) are inflamed and scarred, and emphysema, in which the alveoli (tiny air sacs) are damaged. It develops over many years and is usually caused by cigarette smoking.
Chronic obstructive pulmonary disease (COPD) refers to chronic bronchitis, emphysema, and alpha-1 antitrypsin deficiency, a genetic form of emphysema. COPD is characterized by the obstruction of airflow and interference with normal breathing. Chronic bronchitis and emphysema frequently coexist. Smoking is the primary risk factor for COPD.
Chronic bronchitis and emphysema frequently coexist. Smoking is the primary risk factor for COPD. Other risk factors include secondhand smoke, a history of childhood respiratory infections, heredity, and air pollution. Occupational exposure to certain industrial pollutants also may increase the odds for developing COPD.
Smoking is the primary risk factor for COPD. Other risk factors include secondhand smoke, a history of childhood respiratory infections, heredity, and air pollution. Occupational exposure to certain industrial pollutants also may increase the odds for developing COPD.
Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Emphysema begins with the irreversible destruction of air sacs (alveoli) in the lungs where oxygen from the air is exchanged for carbon dioxide in the blood.
Exacerbation of COPD. Exacerbation is defined as a decompensation of a chronic condition. It is also defined as an increased severity of asthma symptoms, such as wheezing and shortness of breath. Although an infection can trigger it, an exacerbation is not the same as an infection superimposed on a chronic condition.
Status asthmaticus is a continuous obstructive asthmatic state unrelieved after initial therapy measures. If a physician documents both exacerbation and status asthmaticus on the same record, only assign the fifth digit “1” to show the status asthmaticus.
By far, the most important and effective treatment for COPD is smoking cessation. The benefits of quitting smoking apply regardless of age, amount smoked, or severity of COPD. Medications used to manage COPD include the following: